NCT05836883View on ClinicalTrials.gov

Study of ExoFlo for the Treatment of Perianal Fistulas

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
Perianal FistulaCrohn's Disease
Interventions
BIOLOGICAL

ExoFlo

Local injection of bone marrow mesenchymal stem cell derived extracellular vesicles

OTHER

Local injection of normal saline

Placebo

Trial Locations (1)

90048

Direct Biologics Investigational Site, Los Angeles

Sponsors
All Listed Sponsors
lead

Direct Biologics, LLC

INDUSTRY